Related Experiment Videos
Suspected ifosfamide-induced neurotoxicity
1Center for Cell and Gene Therapy, Blood and Marrow Transplantation, The Methodist Hospital, Houston, Texas 77030, USA.
Pharmacotherapy
|December 22, 1999
Summary
Ifosfamide can cause neurotoxicity due to its metabolite, chloroacetaldehyde, which crosses the blood-brain barrier. Treatment decisions for ifosfamide-induced neurotoxicity require individual patient assessment due to limited supporting literature.
Area of Science:
- Oncology
- Pharmacology
- Neuroscience
Background:
- Ifosfamide is an antineoplastic agent requiring hepatic activation.
- Metabolism produces cytotoxic ifosforamide mustard and chloroacetaldehyde.
- Chloroacetaldehyde is structurally similar to chloral hydrate and acetaldehyde.
Observation:
- Chloroacetaldehyde crosses the blood-brain barrier.
- This metabolite is a potential cause of ifosfamide-induced neurotoxicity.
- Neurotoxicity necessitates careful individual patient evaluation.
Findings:
- The mechanism of ifosfamide neurotoxicity involves the metabolite chloroacetaldehyde.
- Differential diagnosis for neurotoxicity includes infection, lab abnormalities, and other drugs.
- Current literature supporting treatments like IV albumin and methylene blue is minimal.
Implications:
- Highlights the importance of monitoring for neurotoxicity in patients receiving ifosfamide.
- Suggests further research into the neurotoxic mechanisms of ifosfamide metabolites.
- Underscores the need for evidence-based treatment guidelines for ifosfamide-induced neurotoxicity.